Skip Navigation

European Journal of Heart Failure 2007 9(4):415-423; doi:10.1016/j.ejheart.2006.10.003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by de Silva, R.
Right arrow Articles by Cleland, J. G.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Silva, R.
Right arrow Articles by Cleland, J. G.F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society of Cardiology

Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure

Ramesh de Silvaa,*, Nikolay P. Nikitina, Klaus K.A. Wittea, Alan S. Rigbya, Huan Loha, Anthony Nicholsonb, Sunil Bhandaric, Andrew L. Clarka and John G.F. Clelanda

a Department of Cardiology, University of Hull, Castle Hill Hospital Kingston upon Hull, East Yorkshire, HU16 5JQ, United Kingdom
b Department of Vascular Radiology, Leeds General Infirmary Leeds, West Yorkshire, LS1 3EX, United Kingdom
c Department of Nephrology, Hull Royal Infirmary Kingston upon Hull, East Yorkshire, HU3 2JZ, United Kingdom

* Corresponding author. Tel.: +44 1482 624073, +44 7931 581 623(Mobile); fax: +44 1482 624085. E-mail address: ramesh{at}desilva84.freeserve.co.uk


   Abstract

Background: No specific guidelines exist on how to manage renal dysfunction (RD) in patients with chronic heart failure (CHF).

Aims: To identify the proportion of patients with moderate to severe RD and CHF who showed an improvement in their renal function in response to a systematic management algorithm.

Methods: Stable patients with CHF and RD (defined by a serum creatinine (SCr) of >130 µmol/l (>1.5 mg/dl)) were enrolled into a systematic management algorithm. The following changes were implemented: switching aspirin to clopidogrel, halving the dose of both diuretics and angiotensin converting enzyme (ACE) inhibitors and switching between bisoprolol and carvedilol.

Results: Two thirds of patients in whom diuretics were reduced, and one fifth of patients in whom ACE inhibitors were reduced, improved their SCr by >25.5 µmol/l (0.3 mg/dl). All these changes were more marked in the presence of bilateral renal artery stenosis. Compared to a reference group, in whom no changes were implemented, the treatment group showed an improvement in their mean SCr by 35 µmol/l (0.4 mg/dl), p<0.001.

Conclusion: Manipulation of pharmacological therapy for patients with CHF and RD results in a substantial recovery of renal function in a minority of patients.

Key Words: Chronic heart failure • Renal dysfunction • Renal artery stenosis

Received April 22, 2006; Revised August 2, 2006; Accepted October 4, 2006


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
Y. Amsalem, M. Garty, R. Schwartz, A. Sandach, S. Behar, A. Caspi, S. Gottlieb, D. Ezra, B. S. Lewis, and J. Leor
Prevalence and significance of unrecognized renal insufficiency in patients with heart failure
Eur. Heart J., April 2, 2008; 29(8): 1029 - 1036.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.